Bayer | BAYN - PE Price to Earnings


Bayer reported 3.4 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Air Liquide 25.71 0.96 Dec/2025
Akzo Nobel 56.72 13.65 Jun/2026
Alcon AG 36.42 1.77 Mar/2026
Amarin 91.05 88.3 Jun/2023
Arkema 33.76 4.01 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
BASF 10.03 6.62 Jun/2026
Bayer 3.4 8.75 Mar/2026
Beiersdorf 22.05 2.86 Dec/2025
Corteva 26.37 0.24 Jun/2026
Covestro 7.54 0 Jun/2024
Essilor 61.39 7.22 Jun/2026
Fresenius 11.44 4.91 Jun/2026
Fresenius Medical Care 6.64 2.07 Mar/2026
Genmab 17.14 4.39 Dec/2025
Givaudan 27.41 4.3 Dec/2025
GlaxoSmithKline 10.63 4.24 Jun/2026
GRIFOLS 14.71 3.73 Jun/2026
Henkel 13.18 0.37 Jun/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Johnson Matthey 36.25 18.8 Jun/2026
Linde 33.48 8.66 Mar/2026
Lonza 34.34 2.58 Dec/2025
Merck 12.74 7.82 Mar/2026
Novartis 22.41 2.24 Jun/2026
Nutrien 11.79 2.54 Jun/2026
Philips 23.76 9.44 Jun/2026
PPG Industries 17.38 1.93 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
SAP 24.08 6.82 Mar/2026
Solvay 94.5 84.8 Jun/2026
UCB 29.7 5.52 Dec/2025
Umicore 4.86 1.8 Dec/2025
Vinci 14.45 0.45 Jun/2026